Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Camp

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cureus|August 27, 2025
Management of Isolated Axillary Recurrence in Breast Cancer: Is There a Role for Targeted Axillary Dissection?Christina M Paluskievicz, Mahtab Vasigh, Piyush Rath, et al.
JAMA Surgery|July 12, 2013
Missing consent forms in the preoperative area: a single-center assessment of the scope of the problem and its downstream effectsJacqueline M Garonzik-Wang, Gabriel Brat, Jose H Salazar, et al.
The Breast Journal|January 1, 2025
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer RiskKala Visvanathan, Ashley Cimino-Mathews, Mary Jo Fackler, et al.
Journal of Cancer Survivorship : Research and Practice|December 8, 2023
The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patientsKala Visvanathan, Dana Petry, Michelle S McCullough, et al.
Breast Cancer Research and Treatment|October 26, 2019
Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?Youngjee Choi, Katherine C Smith, Aishwarya Shukla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2021
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast CancerRoisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2019
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast CancerRoisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cureus|August 27, 2025
Management of Isolated Axillary Recurrence in Breast Cancer: Is There a Role for Targeted Axillary Dissection?Christina M Paluskievicz, Mahtab Vasigh, Piyush Rath, et al.
JAMA Surgery|July 12, 2013
Missing consent forms in the preoperative area: a single-center assessment of the scope of the problem and its downstream effectsJacqueline M Garonzik-Wang, Gabriel Brat, Jose H Salazar, et al.
The Breast Journal|January 1, 2025
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer RiskKala Visvanathan, Ashley Cimino-Mathews, Mary Jo Fackler, et al.
Journal of Cancer Survivorship : Research and Practice|December 8, 2023
The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patientsKala Visvanathan, Dana Petry, Michelle S McCullough, et al.
Breast Cancer Research and Treatment|October 26, 2019
Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?Youngjee Choi, Katherine C Smith, Aishwarya Shukla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2021
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast CancerRoisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2019
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast CancerRoisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Pageof 3